COLOMBO NICOLETTA

Ruolo: 
Professore associato
Settore scientifico disciplinare: 
GINECOLOGIA E OSTETRICIA (MED/40)

Pubblicazioni

  • Gori, S., Barberis, M., Bella, M., Buttitta, F., Capoluongo, E., Carrera, P., et al. (2019). Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 140, 67-72. Dettaglio
  • Korach, J., Colombo, N., Mendiola, C., Selle, F., Dolado, I., Donica, M., et al. (2019). Outcome according to residual disease (surgeon's report vs pre-chemotherapy imaging) in patients with bevacizumab-treated ovarian cancer: Analysis of the ROSiA study. JOURNAL OF SURGICAL ONCOLOGY, 120(4), 786-793. Dettaglio
  • Colombo, N., Zaccarelli, E., Baldoni, A., Frezzini, S., Scambia, G., Palluzzi, E., et al. (2019). Multicenter, randomised, open-label, non-comparative phase 2 trial on the efficacy and safety of the combination of bevacizumab and trabectedin with or without carboplatin in women with partially platinum-sensitive recurrent ovarian cancer. BRITISH JOURNAL OF CANCER. Dettaglio
  • Vergote, I., du Bois, A., Floquet, A., Rau, J., Kim, J., del Campo, J., et al. (2019). Overall survival results of AGO-OVAR16: A phase 3 study of maintenance pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced ovarian cancer. GYNECOLOGIC ONCOLOGY. Dettaglio
  • Colombo, N., Sessa, C., Bois, A., Ledermann, J., Mccluggage, W., Mcneish, I., et al. (2019). ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 29(4), 728-760. Dettaglio